Omnicare shareholder ValueAct continues to sell shares, cuts stake to 3.2%

By Lisa Kerner

Charlotte, N.C., Dec. 2 - Investors led by ValueAct Capital Master Fund, LP sold 2,413,563 shares of Omnicare, Inc., reducing their interest in the company to 3.2% from 4.8%.

According to a schedule 13D/A filed with the Securities and Exchange Commission, the shares were sold between Nov. 12 and Nov. 26 at prices from $22.11 to $24.18 each.

Between Nov. 4 and Nov. 11, ValueAct sold 3,332,987 shares, it was reported in a prior SEC filing.

ValueAct beneficially owns approximately 3.73 million shares of the Covington, Ky., geriatric pharmaceutical services company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.